Molecular Recognition of Candida albicans (1→2)-β-Mannan Oligosaccharides by a Protective Monoclonal Antibody Reveals the Immunodominance of Internal Saccharide Residues*

Background: A Candida albicans vaccine could prevent life-threatening systemic infections. Results: A model of a protective antibody developed by NMR, chemical mapping, and computer simulations accounts for strong recognition of the reducing terminal monosaccharide of di- and trimannoside epitopes. Conclusion: Man(β1–2)Man(β1–2)Man(α- is the optimal oligosaccharide for a conjugate vaccine because internal antigenic determinants dominate recognition of (1→2)-β-mannans. Significance: Structural information of antibody-carbohydrate interactions identified a candidate conjugate vaccine. A self-consistent model of β-mannan oligosaccharides bound to a monoclonal antibody, C3.1, that protects mice against Candida albicans has been developed through chemical mapping, NMR spectroscopic, and computational studies. This antibody optimally binds di- and trisaccharide epitopes, whereas larger oligomers bind with affinities that markedly decrease with increasing chain length. The (1→2)-β-linked di-, tri-, and tetramannosides bind in helical conformations similar to the solution global minimum. Antibody recognition of the di- and trisaccharide is primarily dependent on the mannose unit at the reducing end, with the hydrophobic face of this sugar being tightly bound. Recognition of a tetrasaccharide involves a frameshift in the ligand interaction, shown by strong binding of the sugar adjacent to the reducing end. We show that frameshifting may also be deliberately induced by chemical modifications. Molecular recognition patterns similar to that of mAb C3.1, determined by saturation transfer difference-NMR, were also observed in polyclonal sera from rabbits immunized with a trisaccharide glycoconjugate. The latter observation points to the importance of internal residues as immunodominant epitopes in (1→2)-β-mannans and to the viability of a glycoconjugate vaccine composed of a minimal length oligosaccharide hapten.

• Publication year

  2012

• Venue

  Journal of Biological Chemistry

• Publication date

  2012-04-05

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1074/jbc.M112.355578PMID 22493450PMCID PMC3365708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Designing a Candida albicans Conjugate Vaccine by Reverse Engineering Protective Monoclonal Antibodies

  2012cited by this paper
• Synthesis of three trisaccharide congeners to investigate frame shifting of β1,2-mannan homo-oligomers in an antibody binding site.

  2012cited by this paper
• Close-up of the Immunogenic α1,3-Galactose Epitope as Defined by a Monoclonal Chimeric Immunoglobulin E and Human Serum Using Saturation Transfer Difference (STD) NMR

  2011cited by this paper
• The contribution of mouse models to our understanding of systemic candidiasis.

  2011cited by this paper
• Prospects for Development of a Vaccine to Prevent and Control Vaginal Candidiasis

  2011cited by this paper
• AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

  2009cited by this paper
• Synthesis of monodeoxy and mono-O-methyl congeners of methyl beta-D-mannopyranosyl-(1-->2)-beta-D-mannopyranoside for epitope mapping of anti-Candida albicans antibodies.

  2009cited by this paper
• Synthesis of monodeoxy and mono-O-methyl congeners of methyl beta-D-mannopyranosyl-(1-->2)-beta-D-mannopyranoside for epitope mapping of anti-Candida albicans antibodies.

  2009cited by this paper
• Synthetic glycopeptide vaccines combining β-mannan and peptide epitopes induce protection against candidiasis

  2008cited by this paper
• A Uniquely Small, Protective Carbohydrate Epitope May Yield a Conjugate Vaccine for Candida albicans

  2008cited by this paper
• GLYCAM06: A generalizable biomolecular force field. Carbohydrates

  2008cited by this paper
• Synthesis and immunochemical studies on a Candida albicans cluster glycoconjugate vaccine.

  2007cited by this paper
• Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms.

  2007cited by this paper
• Advances in topical and systemic antifungals.

  2007cited by this paper
• Neonatal invasive candidiasis.

  2006cited by this paper
• Defining criteria for anti-mannan antibodies to protect against candidiasis.

  2005cited by this paper
• Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality

  2005cited by this paper
• Direct observation of ligand binding to membrane proteins in living cells by a saturation transfer double difference (STDD) NMR spectroscopy method shows a significantly higher affinity of integrin alpha(IIb)beta3 in native platelets than in liposomes.

  2005cited by this paper
• Candida albicans cell wall glycans, host receptors and responses: elements for a decisive crosstalk.

  2004cited by this paper
• A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations

  2003cited by this paper
• Synthesis of Di‐ to Hexasaccharide 1,2‐Linked β‐Mannopyranan Oligomers, a Terminal S‐Linked Tetrasaccharide Congener and the Corresponding BSA Glycoconjugates.

  2002cited by this paper
• Effective Born radii in the generalized Born approximation: The importance of being perfect

  2002cited by this paper
• The Unique Solution Structure and Immunochemistry of theCandida albicans β-1,2-Mannopyranan Cell Wall Antigens* 210

  2002cited by this paper
• Synthesis of di- to hexasaccharide 1,2-linked beta-mannopyranan oligomers, a terminal S-linked tetrasaccharide congener and the corresponding BSA glycoconjugates.

  2001cited by this paper
• WAM: an improved algorithm for modelling antibodies on the WEB.

  2000cited by this paper
• Protection against Candidiasis by an Immunoglobulin G3 (IgG3) Monoclonal Antibody Specific for the Same Mannotriose as an IgM Protective Antibody

  2000cited by this paper
• Emerging issues in nosocomial fungal infections

  1999cited by this paper
• Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy.

  1999cited by this paper
• Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.

  1999cited by this paper
• NMR experiments reveal distinct antibody-bound conformations of a synthetic disaccharide representing a general structural element of bacterial lipopolysaccharide epitopes.

  1999cited by this paper
• Assessing protein structures with a non-local atomic interaction energy.

  1998influential reference
• A Vaccine and Monoclonal Antibodies That Enhance Mouse Resistance to Candida albicans Vaginal Infection

  1998cited by this paper
• VERIFY3D: assessment of protein models with three-dimensional profiles.

  1997cited by this paper
• Definitive chemical evidence for the constitutive ability of Candida albicans serotype A strains to synthesize β‐1,2 linked oligomannosides containing up to 14 mannose residues

  1997cited by this paper
• Suppression of spin diffusion in selected frequency bands of nuclear Overhauser spectra

  1996cited by this paper
• Antibody response that protects against disseminated candidiasis

  1995cited by this paper
• Water Suppression That Works. Excitation Sculpting Using Arbitrary Wave-Forms and Pulsed-Field Gradients

  1995cited by this paper
• Molecular recognition of a Salmonella trisaccharide epitope by monoclonal antibody Se155-4.

  1994cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• Assessment of protein models with three-dimensional profiles

  1992cited by this paper
• Structural study on a phosphorylated mannotetraose obtained from the phosphomannan of Candida albicans NIH B-792 strain by acetolysis.

  1991cited by this paper
• Structure of the D-mannan of Candida stellatoidea IFO 1397 strain. Comparison with that of the phospho-D-mannan of Candida albicans NIH B-792 strain.

  1990cited by this paper
• Structural study of cell wall phosphomannan of Candida albicans NIH B-792 (serotype B) strain, with special reference to 1H and 13C NMR analyses of acid-labile oligomannosyl residues.

  1990cited by this paper
• Structural study of phosphomannan of yeast-form cells of Candida albicans J-1012 strain with special reference to application of mild acetolysis.

  1989cited by this paper
• Modeling antibody hypervariable loops: a combined algorithm.

  1989cited by this paper
• Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase‐trimethoprim, a drug‐receptor system

  1988cited by this paper
• Characterization of phosphomannan-protein complexes isolated from viable cells of yeast and mycelial forms of Candida albicans NIH B-792 strain by the action of Zymolyase-100T.

  1986cited by this paper
• An immunochemical study of the combining site specificities of C57BL/6J monoclonal antibodies to alpha (1----6)-linked dextran B512.

  1985cited by this paper
• Structure and Immunological Specificity of Polysaccharides

  1960cited by this paper
• The upper limit for the size of the human antidextran combining site.

  1960cited by this paper

• Fluorinated Glycan Frameshifts: Automated Synthesis Expedites the Study of Glycan-Protein Interactions by 19F-BioNMR.

  2026cites this paper
• Exploring the structural basis and functional immunodynamics of immunoglobulin M in host defense against fungal pathogens

  2025cites this paper
• Synthesis and immunochemical studies of linear oligoglucosides structurally related to the cyclic β-(1→2)-d-glucan of Brucella

  2025cites this paper
• Serum antibody screening using glycan arrays.

  2024cites this paper
• Selective Recognition of Carbohydrate Antigens by Germline Antibodies Isolated from AID Knockout Mice.

  2022cites this paper
• Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance

  2022cites this paper
• Dissection of the anti-Candida albicans mannan immune response using synthetic oligomannosides reveals unique properties of β-1,2 mannotriose protective epitopes

  2021cites this paper
• Reinvestigation of Carbohydrate Specificity of EBCA-1 Monoclonal Antibody Used for the Detection of Candida Mannan

  2021cites this paper
• Antifungal glycoconjugate vaccines

  2020cites this paper
• Synthetic carbohydrate based anti-fungal vaccines.

  2020cites this paper
• Sanguinarine Inhibits Mono- and Dual-Species Biofilm Formation by Candida albicans and Staphylococcus aureus and Induces Mature Hypha Transition of C. albicans

  2020cites this paper
• Pre-clinical Imaging of Invasive Candidiasis Using ImmunoPET/MR

  2018cites this paper
• Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development

  2018cites this paper
• A combined computational-experimental approach to define the structural origin of antibody recognition of sialyl-Tn, a tumor-associated carbohydrate antigen

  2018cites this paper
• Substoichiometric FeCl3 Activation of Propargyl Glycosides for the Synthesis of Disaccharides and Glycoconjugates

  2018cites this paper
• Predicting the Structures of Glycans, Glycoproteins, and Their Complexes.

  2018cites this paper
• Complex carbohydrate recognition by proteins: Fundamental insights from bacteriophage cell adhesion systems

  2017cites this paper
• Immune Recognition of Fungal Polysaccharides

  2017cites this paper
• Candida albicans-derived mannoproteins activate NF-κB in reporter cells expressing TLR4, MD2 and CD14

  2017cites this paper
• Synthesis of β-(1→2)-Linked 6-Deoxy-l-altropyranose Oligosaccharides via Gold(I)-Catalyzed Glycosylation of an ortho-Hexynylbenzoate Donor.

  2017cites this paper
• Glycan Recognition Diversemolecular recognition properties of blood group A binding monoclonal antibodies

  2016cites this paper
• Diverse molecular recognition properties of blood group A binding monoclonal antibodies.

  2016cites this paper
• Chemical Insight into the Mechanism and Specificity of GlfT2, a Bifunctional Galactofuranosyltransferase from Mycobacteria.

  2016cites this paper
• Recent Advances in NMR Studies of Carbohydrates

  2016cites this paper
• [Demonstration of β-1,2 mannan structures expressed on the cell wall of Candida albicans yeast form but not on the hyphal form by using monoclonal antibodies].

  2015cites this paper
• Synthesis of antifungal vaccines by conjugation of β-1,2 trimannosides with T-cell peptides and covalent anchoring of neoglycopeptide to tetanus toxoid.

  2015cites this paper
• Structural characterization of antibodies against lipopolysaccharide antigens: Insights into primary antibody response

  2015cites this paper
• The protective role of immunoglobulins in fungal infections and inflammation

  2015influential citation
• Antibody recognition of carbohydrate epitopes†.

  2015influential citation
• Synthetic Enterobacterial Common Antigen (ECA) for the Development of a Universal Immunotherapy for Drug-Resistant Enterobacteriaceae.

  2015cites this paper
• Expression, purification and characterization of carbohydrate-binding proteins

  2014cites this paper
• Synthesis and conformational analysis of phosphorylated β-(1→2) linked mannosides.

  2014cites this paper
• Discovery of protective B‐cell epitopes for development of antimicrobial vaccines and antibody therapeutics

  2014cites this paper
• Computational evaluations of charge coupling and hydrogen bonding in the active site of a family 7 cellobiohydrolase.

  2014cites this paper
• The Evolution of a Glycoconjugate Vaccine for Candida albicans

  2014cites this paper
• This information is current as-Glucan β Cells via Dectin-1 by Incorporating Conjugate Vaccine Targeted to Dendritic Tricomponent Mannan Tetanus Toxoid Enhanced Immunogenicity of a Ostergaard

  2013cites this paper
• Designing a new antifungal glycoconjugate vaccine.

  2013cites this paper
• Single amino acid exchange in bacteriophage HK620 tailspike protein results in thousand-fold increase of its oligosaccharide affinity.

  2013cites this paper
• Enhanced Immunogenicity of a Tricomponent Mannan Tetanus Toxoid Conjugate Vaccine Targeted to Dendritic Cells via Dectin-1 by Incorporating β-Glucan

  2013cites this paper
• Design of a Candida albicans disaccharide conjugate vaccine by reverse engineering a protective monoclonal antibody.

  2012cites this paper
• A β-mannan trisaccharide conjugate vaccine aids clearance of Candida albicans in immunocompromised rabbits.

  2012cites this paper
• Synthesis of three trisaccharide congeners to investigate frame shifting of β1,2-mannan homo-oligomers in an antibody binding site.

  2012cites this paper
• Synthesis of a Candida albicans tetrasaccharide spanning the β1,2-mannan phosphodiester α-mannan junction.

  2012cites this paper